Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury
Ciara M. Shaver, … , Lorraine B. Ware, the Lung Transplant Outcomes Group (LTOG)
Ciara M. Shaver, … , Lorraine B. Ware, the Lung Transplant Outcomes Group (LTOG)
Published January 25, 2018
Citation Information: JCI Insight. 2018;3(2):e98546. https://doi.org/10.1172/jci.insight.98546.
View: Text | PDF
Research Article Pulmonology Transplantation

Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury

  • Text
  • PDF
Abstract

Primary graft dysfunction (PGD) is acute lung injury within 72 hours of lung transplantation. We hypothesized that cell-free hemoglobin (CFH) contributes to PGD by increasing lung microvascular permeability and tested this in patients, ex vivo human lungs, and cultured human lung microvascular endothelial cells. In a nested case control study of 40 patients with severe PGD at 72 hours and 80 matched controls without PGD, elevated preoperative CFH was independently associated with increased PGD risk (odds ratio [OR] 2.75, 95%CI, 1.23–6.16, P = 0.014). The effect of CFH on PGD was magnified by reperfusion fraction of inspired oxygen (FiO2) ≥ 0.40 (OR 3.41, P = 0.031). Isolated perfused human lungs exposed to intravascular CFH (100 mg/dl) developed increased vascular permeability as measured by lung weight (CFH 14.4% vs. control 0.65%, P = 0.047) and extravasation of Evans blue–labeled albumin dye (EBD) into the airspace (P = 0.027). CFH (1 mg/dl) also increased paracellular permeability of human pulmonary microvascular endothelial cell monolayers (hPMVECs). Hyperoxia (FiO2 = 0.95) increased human lung and hPMVEC permeability compared with normoxia (FiO2 = 0.21). Treatment with acetaminophen (15 μg/ml), a specific hemoprotein reductant, prevented CFH-dependent permeability in human lungs (P = 0.046) and hPMVECs (P = 0.037). In summary, CFH may mediate PGD through oxidative effects on microvascular permeability, which are augmented by hyperoxia and abrogated by acetaminophen.

Authors

Ciara M. Shaver, Nancy Wickersham, J. Brennan McNeil, Hiromasa Nagata, Adam Miller, Stuart R. Landstreet, Jamie L. Kuck, Joshua M. Diamond, David J. Lederer, Steven M. Kawut, Scott M. Palmer, Keith M. Wille, Ann Weinacker, Vibha N. Lama, Maria M. Crespo, Jonathan B. Orens, Pali D. Shah, Chadi A. Hage, Edward Cantu III, Mary K. Porteous, Gundeep Dhillon, John McDyer, Julie A. Bastarache, Jason D. Christie, Lorraine B. Ware, the Lung Transplant Outcomes Group (LTOG)

×

Figure 4

Schematic of ex vivo isolated perfused lung preparation.

Options: View larger image (or click on image) Download as PowerPoint
Schematic of ex vivo isolated perfused lung preparation.
Lungs were susp...
Lungs were suspended from a mass transducer and were continuously perfused at 37°C with DMEM containing 5% albumin and 16% (v/v) fresh whole human blood by roller pump to maintain a pulmonary artery pressure of 10–12 mmHg with passive drainage of perfusate through an open left atrium (53, 54). Lungs were inflated to continuous positive end-expiratory pressure of 10 mmHg with either an FiO2 of 0.95 or of 0.21. The lung was suspended from a mass transducer for continuous measurement of lung weight as an index of pulmonary edema formation.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts